- Report
- May 2025
- 189 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- March 2025
- 200 Pages
Global
From €2230EUR$2,490USD£1,901GBP
- Report
- June 2025
- 89 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- August 2024
- 150 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- March 2025
- 585 Pages
Global
From €6265EUR$6,995USD£5,341GBP
- Report
- May 2025
- 192 Pages
Global
From €4165EUR$4,650USD£3,550GBP
- Report
- May 2025
- 183 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 199 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 195 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- March 2025
- 181 Pages
Asia Pacific
From €2553EUR$2,850USD£2,176GBP
- Report
- August 2024
- 120 Pages
India
From €2418EUR$2,700USD£2,062GBP
- Report
- November 2021
- 255 Pages
Global
From €4926EUR$5,500USD£4,199GBP
- Report
- May 2021
- 174 Pages
Global
From €2463EUR$2,750USD£2,100GBP
- Report
- December 2022
- 223 Pages
Global
From €2351EUR$2,625USD£2,004GBP
€4702EUR$5,250USD£4,009GBP
- Report
- December 2023
- 152 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- May 2024
- 184 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- April 2023
- 124 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- February 2024
- 117 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- May 2022
- 180 Pages
Global
From €3986EUR$4,450USD£3,398GBP

The Prostate Cancer Diagnostics market is a segment of the Diagnostics industry that focuses on the detection and diagnosis of prostate cancer. Diagnostic tests for prostate cancer include digital rectal exams, prostate-specific antigen (PSA) tests, and biopsies. These tests are used to detect the presence of cancer, as well as to monitor the progression of the disease.
In recent years, advances in technology have enabled the development of more accurate and reliable diagnostic tests for prostate cancer. These tests have improved the accuracy of diagnosis and have enabled earlier detection of the disease. Additionally, the development of new treatments for prostate cancer has increased the demand for diagnostic tests.
The Prostate Cancer Diagnostics market is highly competitive, with a number of companies offering a range of diagnostic tests. Some of the major players in the market include Abbott Laboratories, Becton Dickinson, Siemens Healthineers, and Roche Diagnostics. Show Less Read more